Stem cell therapy for central nervous system demyelinating disease

被引：14
|
作者：
Manganas L.N. [1 ]
Maletic-Savatic M. [1 ]
机构：
[1] Department of Neurology, Stony Brook University, Stony Brook
来源：
Current Neurology and Neuroscience Reports | 2005年 / 5卷 / 3期
关键词：
Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Neural Stem Cell; Stem Cell Therapy; Bone Marrow Stem Cell;
D O I：
10.1007/s11910-005-0050-z
中图分类号：
学科分类号：
摘要：
Recent advances in cell-based therapies for demyelinating central nervous system diseases have demonstrated the ability to restore damaged neuronal architecture and function. Demyelinated axons in patients with multiple sclerosis can spontaneously remyelinate over time; however, the rate and extent at which remyelination occurs is inadequate for complete recovery. Previous attempts aimed at regenerating myelin-forming cells have been successful but limited by the multifocal nature of the lesions and the inability to produce large numbers of myelin-producing cells in culture. Stem cell-based therapy can overcome these limitations to some extent and may prove useful in the future treatment of demyelinating diseases. Copyright © 2005 by Current Science Inc.
引用
收藏
页码：225 / 231
页数：6
相关论文
共 50 条
  • [41] Stem cell repair of the central nervous system
    Low, Walter
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S26 - S26
  • [42] Syringomyelia in Demyelinating Disease of the Central Nervous System: Report of Two Cases
    Savic, Dejan
    Vojinovic, Slobodan
    Spasic, Mirjana
    Peric, Zoran
    Lukic, Stevo
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2011, 139 (9-10) : 657 - 660
  • [43] Monophasic demyelinating disease of the central nervous system associated with Hepatitis A infection
    L. Quaranta
    A. P. Batocchi
    M. Sabatelli
    V. Nociti
    T. Tartaglione
    F. Cuonzo
    P. A. Tonali
    Journal of Neurology, 2006, 253
  • [44] Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System
    Ottoboni, Linda
    Merlini, Arianna
    Martino, Gianvito
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2017, 5
  • [45] Stem and progenitor cell-based therapy of the human central nervous system
    Goldman, S
    NATURE BIOTECHNOLOGY, 2005, 23 (07) : 862 - 871
  • [46] Neural Stem Cell Therapy and Rehabilitation in the Central Nervous System: Emerging Partnerships
    Ross, Heather H.
    Ambrosio, Fabrisia
    Trumbower, Randy D.
    Reier, Paul J.
    Behrman, Andrea L.
    Wolf, Steven L.
    PHYSICAL THERAPY, 2016, 96 (05): : 734 - 742
  • [47] Microglia in cell culture and in transplantation therapy for central nervous system disease
    Dobrenis, K
    METHODS, 1998, 16 (03) : 320 - 344
  • [48] Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders
    Allegretta, Caterina
    D'Amico, Emanuele
    Manuti, Virginia
    Avolio, Carlo
    Conese, Massimo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [49] The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system
    Furlan, R
    Pluchino, S
    Martino, G
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (03) : 385 - 392
  • [50] Fulminant Demyelinating Diseases of the Central Nervous System
    Bevan, Carolyn J.
    Cree, Bruce A.
    SEMINARS IN NEUROLOGY, 2015, 35 (06) : 656 - 666
12345